PT Pyridam Farma Tbk Net Income

The latest net income for PYFA.JK is $-340B as of June 2026. That compares with $-430B in the prior-year period — up 19.5% year over year. That is below the sector sector average of $1.7T. Investors often review this figure alongside PT Pyridam Farma Tbk's historical trend and sector peers before judging valuation or financial health.

Over the past year, PYFA.JK's net income moved from $-430B to $-340B — a 19.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in PT Pyridam Farma Tbk's operating scale or balance-sheet position.

Against its sector companies, PYFA.JK currently prints $-340B for net income, while the sector average sits near $1.7T. That is roughly 120.5% below the sector mean. Large gaps often invite a closer look at PT Pyridam Farma Tbk's growth, margins, and balance sheet.

A net income figure of $-340B for PYFA.JK is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $1.7T. Explore the charts below for those layers of context.

After noting PYFA.JK's net income ($-340B), review year-over-year change from $-430B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.